denovoSkin (c) Frank Brüderli

A tissue therapeutics revolution

CUTISS is a late-stage clinical TechBio company and a global leader in skin tissue therapeutics. We are transforming skin surgery with denovoSkin™, our first-in-class personalized tissue therapy which enables scaled, automated, and on-demand skin production. 

Developed for patients requiring skin grafts due to a wide range of indications – from massive burns to reconstructive and aesthetic applications – denovoSkin™ has demonstrated safety and efficacy compared to the standard of care, with significantly improved scar quality.

Production

CUTISS manufactures its lead product for clinical use
in its state of the art, certified Good Manufacturing Practice Facility
in Schlieren near Zurich.

Insight CUTISS AG Video Overlay

Automation

CUTISS has developed first-in-class machine for the automated production of tissue therapy. To secure scale-up, allow decentralization and achieve relevant cost reduction for the manufacturing of denovoSkin, CUTISS has been developing first-in-class automated bio-reactors with leading Swiss and international engineering partners. This pioneering, proprietary platform may also be used beyond skin for the next-priority human tissues (muscle, gums, etc.) in the future. 

Scroll to Top

Newsletter

Would you like to contact us as a journalist?

©WyssZurich

This website uses cookies to ensure you get the best experience on our website.